Comparing Levovist-enhanced pulse inversion harmonic imaging and ferumoxides-enhanced MR imaging of hepatic metastases

American Journal of Roentgenology

Volumn 180, Issue 5, 2003, Pages 1339-1346

  Del Frate, Chiara ^a,b   Zuiani, Chiara ^a   Londero, Viviana ^a   Como, Giuseppe ^a   Bazzocchi, Massimo ^a   Mortele, Koenraad ^b   Ros, Pablo R ^b  

^a UNIVERSITY OF UDINE   (Italy)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIDEX; SHU 508; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; ECHOGRAPHY; FEMALE; HUMAN; IMAGE QUALITY; LIVER METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PEROPERATIVE ECHOGRAPHY; PRIORITY JOURNAL; PULSE INVERSION HARMONIC IMAGING;

EID: 0037404674     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.180.5.1801339     Document Type: Article

References (31)

1. Campani R, Calliada F, Bottinelli O, et al. Contrast enhancing agents in ultrasonography: clinical application. Eur J Radiol 1998;27:161-170
2. Carter R, Hemingway D, Pickard R, Poom FW, MacKillop JA, McArdle CS. A prospective study of six methods for the detection of hepatic colorectal metastases. Ann R Coll Surg Engl 1996;78:27-30
3. Cosgrove DO, Bolondi L. Malignant liver disease. In: Cosgrove D, Meire H, Dewbury K, eds. Abdominal and general ultrasound. Edinburgh: Churchill Livingstone, 1993:271-293
4. Hagspield KD, Neidl KWF, Eichenberger AC, Weder W, Marincek B. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and nonenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 1995;196:471-478
5. Wernecke K, Rummeny EJ, Bongartz G, et al. Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging. AJR 1991;157:731-739
6. Blomley MJ, Albrecth TA, Cosgrove DO, et al. Improved detection of liver metastases with simulated acoustic emission in late phase of enhancement with the US contrast agent SH U 508: early experience. Radiology 1999;210:409-416
7. Harvey CJ, Blondey MJ, Eckersley RJ, et al. Hepatic malignancies: improved detection with pulse-inversion US in late phase of enhancement with SH U 508A -early experience. Radiology 2000;216:903-908
8. Dalla Palma L, Bertolotto M, Quaia E, Locatelli M. Depiction of liver metastases with pulse inversion harmonic imaging: preliminary results. Eur Radiol 1999;9[suppl 2]:382S-387S
9. Heiken JP, Weyman PJ, Lee JKT, et al. Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging. Radiology 1989;171:47-51
10. Soyer P. CT during arterial portography. Eur Radiol 1996;6:349-357
11. Denys A, Arrivé L, Servois V, et al. Hepatic tumors: detection and characterization at IT MR imaging enhanced with AMI-25. (abstr) Radiology 1994;193(P):665-669
12. Hahn PF, Saini S. Liver specific MR imaging contrast agents. In: Ros PR, ed. The radiologic clinics of North America. Philadelphia: Saunders, 1998;36:287-297
13. Seneterre E, Taourel P, Bouvier Y, et al. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 1996;200:785-792
14. Ros PR, Freeny PC, Harms SE, et al. Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 1995;196:481-488
15. Ferrucci JT, Stark DD. Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years. AJR 1990;155:943-950
16. Bellin MF, Zaim S, Auberton E, et al. Safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. Radiology 1994;193:657-663
17. Duda SH, Laniado M, Kopp AF, et al. Superparamagnetic iron oxide: depiction of focal liver lesions at high-field-strength MR imaging. J Magn Reson Imaging 1994;4:309-314
18. Marchal G, Van Hecke P, Demaerel P, et al. Depiction of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T. AJR 1989;152:771-775
19. Schwartz LH, Seltzer SE, Tempany CM, et al. Superparamagnetic iron oxide hepatic MR imaging: efficacy and safety using conventional and fast spin-echo pulse sequences. J Magn Reson Imaging 1995;5:566-570
20. Taylor PM, Hawnaur JM, Hutchinson CE. Superparamagnetic iron oxide imaging of focal liver disease. Clin Radiol 1995;50:215-219
21. Lencioni R, Donati F, Cioni D, Paolicchi A, Cicorelli A, Bartolozzi C, Detection of colorectal liver metastases: prospective comparison of unenhanced and ferumoxides-enhanced magnetic resonance imaging at 1.5 T, dual-phase spiral CT, and spiral CT during arterial portography. MAGMA 1998;7:76-87
22. Ward J, Naik KS, Guthrie JA, Wlison D, Robinson PJ. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative free response receiver operating characteristic analysis. (abstr) Radiology 1999;210(P):459-466.
23. Reimer P, Jahnke N, Fiebich M, et al. Hepatic lesion detection and characterization: value of non-enhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 2000;217:152-158
24. Bluemke DA, Paulson EK, Choti MA, DeSena S, Clavien PA. Detection of hepatic lesions in candidates for surgery: comparison of ferumoxides-enhanced MR imaging and dual-phase helical CT. AJR 2000;175:1653-1658
25. Kondo H, Kanematsu M, Hoshi H, et al. Preoperative depiction of malignant hepatic tumors: comparison of combined methods of MR imaging with combined methods of CT AJR 2000;174:947-954
26. Vauthey NJ. Liver imaging: a surgeon's perspective. In: Ros PR, ed. The radiologic clinics of North America. Philadelphia: Saunders, 1998;36:287-297
27. Hughes KS, Rosenstein RB, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of longterm survivors. Dis Colon Rectum 1998;31:1-4
28. Blomley MJK, Albrecht T, Cosgorve DO, et al. Stimulated acoustic emission in liver parenchyma with Levovist. Lancet 1998;351:568
29. Burns PN. Harmonic imaging with ultrasound contrast agents. Clin Radiol 1996;51[suppl 1]:50-55
30. Bloomley MJ, Albrecht T, Cosgrove DO, et al. The microbubble Levovist as a liver specific contrast agent: an investigation in healthy volunteers using the stimulated acoustic emission (SAE) phenomenon. (abstr) Radiology 1998;209(P):309
31. Albrecht T, Bauer A, Hoffmann CW. Wideband harmonic B-mode imaging with Levovist: first experiences in humans. (abstr) Radiology 1998;209(P):309